Co-Authors
This is a "connection" page, showing publications co-authored by Airu Zhu and Xiaofang Huang.
Connection Strength
0.286
-
Repurposing carrimycin as an antiviral agent against human coronaviruses, including the currently pandemic SARS-CoV-2. Acta Pharm Sin B. 2021 Sep; 11(9):2850-2858.
Score: 0.058
-
Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients. Genome Med. 2021 02 22; 13(1):30.
Score: 0.058
-
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient. Emerg Microbes Infect. 2020 Dec; 9(1):991-993.
Score: 0.057
-
Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020 10 01; 130(10):5235-5244.
Score: 0.057
-
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. 2020 08 06; 182(3):734-743.e5.
Score: 0.055